Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and Rationale of the Swiss-Apero Randomized Clinical Trial: Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure.
Galea R, De Marco F, Aminian A, Meneveau N, Anselme F, Gräni C, Huber AT, Teiger E, Iriart X, Angelillis M, Brugger N, Spirito A, Corpataux N, Franzone A, Vranckx P, Fischer U, Pedrazzini G, Bedogni F, Windecker S, Räber L, Valgimigli M. Galea R, et al. Among authors: angelillis m. J Cardiovasc Transl Res. 2021 Oct;14(5):930-940. doi: 10.1007/s12265-020-10095-4. Epub 2021 Apr 21. J Cardiovasc Transl Res. 2021. PMID: 33884564
Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA, Testa L, Fraccaro C, Montorfano M, Castriota F, Nerla R, Angelillis M, Tusa M, Giannini F, Garatti A, Tarantini G, Petronio AS, Brambilla N, Bedogni F. Montone RA, et al. Among authors: angelillis m. Catheter Cardiovasc Interv. 2017 Dec 1;90(7):1206-1211. doi: 10.1002/ccd.26914. Epub 2017 Feb 1. Catheter Cardiovasc Interv. 2017. PMID: 28145039
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimarães AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, Zazula A, van Amsterdam RGM, Mehran R, Windecker S; GALILEO Investigators. Dangas GD, et al. N Engl J Med. 2020 Jan 9;382(2):120-129. doi: 10.1056/NEJMoa1911425. Epub 2019 Nov 16. N Engl J Med. 2020. PMID: 31733180 Free article. Clinical Trial.
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis.
Testa L, Latib A, Brambilla N, De Marco F, Fiorina C, Adamo M, Giannini C, Angelillis M, Barbanti M, Sgroi C, Poli A, Ferrara E, Bruschi G, Russo CF, Matteo M, De Felice F, Musto C, Curello S, Colombo A, Tamburino C, Petronio AS, Bedogni F. Testa L, et al. Among authors: angelillis m. Eur Heart J. 2020 May 21;41(20):1876-1886. doi: 10.1093/eurheartj/ehz925. Eur Heart J. 2020. PMID: 31904800
Bicuspid aortic valve sizing for transcatheter aortic valve implantation: Development and validation of an algorithm based on multi-slice computed tomography.
Petronio AS, Angelillis M, De Backer O, Giannini C, Costa G, Fiorina C, Castriota F, Bedogni F, Laborde JC, Søndergaard L. Petronio AS, et al. Among authors: angelillis m. J Cardiovasc Comput Tomogr. 2020 Sep-Oct;14(5):452-461. doi: 10.1016/j.jcct.2020.01.007. Epub 2020 Jan 25. J Cardiovasc Comput Tomogr. 2020. PMID: 32001214
Clinical impact and evolution of mitral regurgitation after TAVI using the new generation self-expandable valves.
Giannini C, Angelillis M, Fiorina C, Tamburino C, Bedogni F, Bruschi G, Montorfano M, Poli A, De Felice F, Reimers B, Branca L, Barbanti M, Testa L, Merlanti B, Petronio AS. Giannini C, et al. Among authors: angelillis m. Int J Cardiol. 2021 Jul 15;335:85-92. doi: 10.1016/j.ijcard.2021.03.071. Epub 2021 Apr 1. Int J Cardiol. 2021. PMID: 33811960
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction.
Angelillis M, Giannini C, De Carlo M, Adamo M, Nardi M, Colombo A, Chieffo A, Bedogni F, Brambilla N, Tamburino C, Barbanti M, Bruschi G, Colombo P, Poli A, Martina P, Violini R, Presbitero P, Petronio AS. Angelillis M, et al. Am J Cardiol. 2017 Nov 1;120(9):1639-1647. doi: 10.1016/j.amjcard.2017.07.064. Epub 2017 Aug 1. Am J Cardiol. 2017. PMID: 28844511
42 results